Insider · CIK 0001402652

Grande Alicia

CIK 0001402652 Name as filed on the most recent filing

Filed as Grande Alicia (15)

34 transaction lines · from 15 filings · filed 2008-11-26 to 2023-12-12 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

34 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2023-12-11 S, Open-market sale Catalyst Pharmaceuticals, Inc.CPRX 2 lines 825,780, disposed Open Form 4 filing 0001161697-23-000610
2023-12-08 S, Open-market sale Catalyst Pharmaceuticals, Inc.CPRX 2 lines 571,000, disposed Open Form 4 filing 0001161697-23-000610
2023-03-29 S, Open-market sale Catalyst Pharmaceuticals, Inc.CPRX 3 lines 835,100, disposed Open Form 4 filing 0001161697-23-000200
2023-03-28 S, Open-market sale Catalyst Pharmaceuticals, Inc.CPRX 4 lines 962,786, disposed Open Form 4 filing 0001161697-23-000200
2023-03-22 S, Open-market sale Catalyst Pharmaceuticals, Inc.CPRX 2 lines 689,528, disposed Open Form 4 filing 0001161697-23-000185
2022-11-22 S, Open-market sale Catalyst Pharmaceuticals, Inc.CPRX 1,983,240, disposed Open Form 4 filing 0001161697-22-000562
2022-11-15 S, Open-market sale Catalyst Pharmaceuticals, Inc.CPRX 946,080, disposed Open Form 4 filing 0001161697-22-000553
2022-09-23 S, Open-market sale Catalyst Pharmaceuticals, Inc.CPRX 713,940, disposed Open Form 4 filing 0001161697-22-000482
2022-09-16 S, Open-market sale Catalyst Pharmaceuticals, Inc.CPRX 1,214,640, disposed Open Form 4 filing 0001161697-22-000479
2022-09-14 S, Open-market sale Catalyst Pharmaceuticals, Inc.CPRX 778,650, disposed Open Form 4 filing 0001161697-22-000467
2022-08-29 S, Open-market sale Catalyst Pharmaceuticals, Inc.CPRX 3 lines 809,560, disposed Open Form 4 filing 0001161697-22-000425
2022-08-26 S, Open-market sale Catalyst Pharmaceuticals, Inc.CPRX 159,768, disposed Open Form 4 filing 0001161697-22-000425
2022-08-18 S, Open-market sale Catalyst Pharmaceuticals, Inc.CPRX 263,848, disposed Open Form 4 filing 0001161697-22-000398
2022-08-17 S, Open-market sale Catalyst Pharmaceuticals, Inc.CPRX 2 lines 1,811,635, disposed Open Form 4 filing 0001161697-22-000398
2021-08-18 S, Open-market sale Catalyst Pharmaceuticals, Inc.CPRX 73,879, disposed Open Form 4 filing 0001161697-21-000393
2021-08-17 S, Open-market sale Catalyst Pharmaceuticals, Inc.CPRX 566,900, disposed Open Form 4 filing 0001161697-21-000393
2012-07-03 P, Open-market purchase Catalyst Pharmaceutical Partners, Inc.CPRX 2 lines 10,980, acquired Open Form 4 filing 0001161697-12-000525
2012-05-30 P, Open-market purchase Catalyst Pharmaceutical Partners, Inc.CPRX 9,861, acquired Open Form 4 filing 0001161697-12-000437
2009-11-19 P, Open-market purchase Catalyst Pharmaceutical Partners, Inc.CPRX 2,730, acquired Open Form 4 filing 0001181431-09-053082
2009-11-18 P, Open-market purchase Catalyst Pharmaceutical Partners, Inc.CPRX 3,250, acquired Open Form 4 filing 0001181431-09-053082
2008-11-25 P, Open-market purchase Catalyst Pharmaceutical Partners, Inc.CPRX 4,625, acquired Open Form 4 filing 0001161697-08-001289
2008-11-24 P, Open-market purchase Catalyst Pharmaceutical Partners, Inc.CPRX 1,850, acquired Open Form 4 filing 0001161697-08-001289

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 7
  • Open-market sale 27
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. GRANDE ALICIA, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001402652

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.